SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-21-018445
Filing Date
2021-08-03
Accepted
2021-08-03 17:00:24
Documents
4
Period of Report
2021-08-03

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 714636
2 logo_1.jpg GRAPHIC 5976
3 proxy_001.jpg GRAPHIC 132121
4 proxy_002.jpg GRAPHIC 93044
  Complete submission text file 0001493152-21-018445.txt   1034349
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-12830 | Film No.: 211140749
SIC: 2836 Biological Products, (No Diagnostic Substances)